Understanding Treatment-Resistant Depression: What You Need to Know

Understanding Treatment-Resistant Depression: What You Need to Know

Depression is a deeply personal journey that looks different for everyone. For many, finding the right treatment can be life-changing, but for some, standard approaches like oral antidepressants don’t seem to work. This experience is known as treatment-resistant depression (TRD), and while it can be discouraging, understanding it is the first step toward discovering new possibilities for relief.

If you’re exploring options like Spravato® but aren’t quite ready or don’t yet qualify, this guide will help you better understand TRD and your potential paths forward.

What Is Treatment-Resistant Depression?

TRD is a type of major depressive disorder (MDD) that doesn’t improve after trying at least two different oral antidepressants at adequate doses for sufficient periods. This doesn’t mean that you’re beyond help—it simply means that your brain may respond differently to traditional treatments, and exploring alternative approaches could be key.

Why Does Depression Sometimes Resist Treatment?

There’s no one-size-fits-all answer, but these factors often play a role:

• Brain chemistry: Each person’s brain processes neurotransmitters like serotonin and dopamine differently.
• Underlying conditions: Conditions such as anxiety, PTSD, or chronic pain can complicate treatment.
• Lifestyle and environment: Stressors, trauma, and physical health can influence how you respond to treatment.
• Genetics: Your genetic makeup may affect how your body metabolizes medications.

How to Approach Treatment-Resistant Depression

While TRD can feel like a roadblock, it’s often an opportunity to explore innovative and personalized solutions. Here’s how:

1. Reassess Your Current Treatment Plan
   Work closely with your doctor to review your medication history, dosage, and treatment duration. Sometimes adjusting one of these factors can lead to improvement.
   
2. Incorporate Therapy
   Combining medication with psychotherapy, such as cognitive-behavioral therapy (CBT) or acceptance and commitment therapy (ACT), often leads to better outcomes.
   
3. Explore Holistic Approaches
   Combining medication with psychotherapy, such as cognitive-behavioral therapy (CBT) or acceptance and commitment therapy (ACT), often leads to better outcomes.
   
4. Understand Your Options Beyond Medications
   For those with TRD, innovative treatments like Spravato® (esketamine nasal spray) are specifically designed to address depression that hasn’t responded to traditional antidepressants.

What Is Spravato®, and How Does It Work?

Spravato® is an FDA-approved treatment for adults with TRD. Unlike oral antidepressants, which primarily target serotonin, Spravato® works on the brain’s glutamate system, promoting new connections between brain cells. Administered under supervision in a medical setting, it provides rapid relief for many patients—often within days or weeks.

It’s important to note that Spravato® is typically considered after trying at least two oral antidepressants. If you’re not there yet, this is an opportunity to focus on maximizing the benefits of your current treatment plan while learning more about how Spravato® could fit into your future care.

Next Steps for Those Exploring Their Options

If you’re feeling unsure or frustrated, you’re not alone. Here are some steps to consider:

• Track your symptoms: Keeping a journal of how you’re feeling can help you and your provider identify patterns and potential triggers.
• Ask questions: Discuss your concerns, treatment goals, and long-term options with your healthcare provider.
• Stay open to new possibilities: Advancements in mental health care are happening all the time, and options like Spravato® may be closer than you think.

Final Thoughts

Living with treatment-resistant depression can be incredibly challenging, but it’s important to remember that it doesn’t define you. Each step you take toward understanding your condition and exploring treatments brings you closer to relief.

If you’re considering your next steps and want to learn more about Spravato® or other treatment options, we’re here to provide support and guidance.

Your well-being matters, and hope is never out of reach.

About Author

Amy Della Rocca

PMHNP – Clinical Director

Meet Amy Della Rocca, a Psychiatric Nurse Practitioner with experience in innovative mental health treatments. Amy’s credentials hail from Columbia University and her previous work experience is in Behavioral Health, Public health and Primary Care Medicine. Amy’s unwavering belief in the potential of ketamine treatment for mental well-being stems from hands-on experience with her patients. Witnessing its positive impact and lasting changes drove her to specialize in this unique field. What sets Amy apart is her holistic approach. She considers medical, emotional, and psychological aspects, earning respect for her practical solutions. Operating from Marpa, Amy evaluates patients for Spravato compatibility. She provides comprehensive on-site care during their Spravato treatment journey. Amy supports patients from evaluation to treatment completion and collaborates with their existing mental and physical health care team. Amy’s contribution goes beyond caregiving; she actively advances Ketamine Therapy. Her expertise and dedication have garnered trust among colleagues and patients alike.